Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
Erin Gatza(Pediatrics and Genetics), Sung Won Choi(University of Michigan), James L.M. Ferrara(Tisch Hospital), Andrew C. Harris(Primary Children's Hospital), Lawrence Chang(University of Michigan), John E. Levine(Icahn School of Medicine at Mount Sinai), Sophie Paczesny(MUSC Hollings Cancer Center), James A. Connelly(Michigan Center for Translational Pathology), Daniel R. Couriel(The University of Texas MD Anderson Cancer Center), Carrie L. Kitko(Vanderbilt University Medical Center), Shuang G. Zhao(University of Wisconsin Carbone Cancer Center), Pavan Reddy(Wichita State University), Gregory A. Yanik(University of Michigan), Tianyi Wang(Shanghai Children's Medical Center), Thomas Braun(University of Michigan), John Magenau(University of Michigan), Steven C. Goldstein(University of Michigan), Attaphol Pawarode(University of Michigan)
Cited by 24
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
|Frontiers in Immunology|2017|612
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577